Susan D. Berland founded Veracyte, Inc.

She is on the board of Senti Biosciences, Inc. and Senti Biosciences, Inc.

Ms. Berland previously was Chief Financial Officer of Poniard Pharmaceuticals, Inc., Chief Financial Officer of Atreca, Inc., Chief Financial Officer of Bluestar Genomics, Inc., Chief Financial Officer at DNA Sciences, Inc., Chief Financial Officer for Mendel Biotechnology, Inc. and Head-Financial Planning at Monsanto Co.

She received an undergraduate degree and an MBA from the University of Wisconsin-Milwaukee.